PON2 and metabolic dysfunction-associated steatotic liver disease: In addition to PON2 and its anti-atherogenic effects, another study showed that an increase in oxidative stress in the liver of rats with NAFLD is also accompanied by decreased hepatic PON2 activity14, suggesting that impaired PON2 activity in liver cells may be closely associated with the development and progression of NAFLD.